Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Research Article

Vol. 6 No. 2 (2002)

A Comparison of Control Populations in Quebec Using the Short Musculoskeletal Function Assessment

  • Craig Lomita, BA
DOI
https://doi.org/10.26443/mjm.v6i2.681
Submitted
November 8, 2020
Published
2002-12-01

Abstract

The Short Musculoskeletal Function Assessment (SMFA) questionnaire is a health status instrument validated in the United States for use with patients with musculoskeletal impairments. It allows patients to self-rate their level of disability and impairment. This questionnaire has never been validated for Canada's English and French speaking populations. The first objective of this study was to determine the baseline responses of a healthy (i.e., without orthopaedic pathology) population representative of English and French speaking Canadians. The second objective was to compare the results of the Short Musculoskeletal Function Assessment to see if language or gender had any significant effect on the responses. A sample population (n=144) of Quebec Francophone and Anglophone subjects was interviewed using the Short Musculoskeletal Function Assessment questionnaire over the course of five weeks. All subjects were obtained from the orthopaedic clinic of the Montreal General Hospital in Montreal, Quebec. All subjects were self-reported as not being orthopaedic patients themselves in the past or present, and were merely accompanying patients of the clinic. Results were analyzed for differences between four groups using the ANOVA statistical test: Francophone females, Francophone males, Anglophone females, and Anglophone males. No statistically significant differences were detected between the four groups. Results were also analyzed for any differences between three age groups using the ANOVA statistical test, (15-35 years, 36-55 years, and 56 and greater years), with no significant differences detected. The overall Short Musculoskeletal Function Assessment values obtained for the four patient populations were: Francophone males = 5.41; Francophone females = 5.40; Anglophone males = 6.41; and Anglophone females males = 5.33. For the three age groups, the results were: 15 - 35 years = 6.87; 36 - 55 years = 5.22; 56 years and greater = 5.18. These results provide an initial baseline to which future orthopaedic patients can be compared, and suggest that analysis of the Short Musculoskeletal Function Assessment results may be compared across gender and language lines within Canada.

References

  1. Center for Disease Control. Prevalence and Impact of Chronic Joint Symptoms -Seven States, 1996. Morbidity & Mortality Weekly Report, 47(17): 345-51, 1998.
  2. Wigle, Donald T. Canada's Health Status: A Public Health Perspective. Risk Analysis, 15 (6): 693-698, 1995.
  3. Swiontkowski MF, Chapman JR. Cost and effectiveness issues in care of injured patients. Clinical Orthopaedics and Related Research, 318: 17-24, 1995.
  4. Keller, RB. Measuring outcomes. Journal of Bone and Joint Surgery, 14: 171-172, 1996.
  5. Meenan RF, Gertman PM, Mason JH. Measuring health status in arthritis: the Arthritis Impact Measurement Scales. Arthritis and Rheumatism, 23: 146-152, 1980.
  6. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30:473-83, 1992.
  7. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. Journal of Rheumatology, 15:1833-1840, 1988.
  8. Swiontkowski MF, Engelberg R, Martin DP, Agel J. Short Musculoskeletal Function Assessment questionnaire: validity, reliability, and responsiveness. Journal of Bone and Joint Surgery, 81: 1245-1260, 1999.
  9. Martin, DP, Engelberg R, Agel J, Snapp D, Swiontkowski MF. Development of a musculoskeletal extremity health-status instrument: the Musculoskeletal Function Assessment instrument. Journal of Bone and Joint Surgery, 14: 173-181, 1996.
  10. Engelberg R, Martin DP, Agel J, Obremsky W, Coronado G, Swiontkowski MF. Musculoskeletal Function Assessment instrument: criterion and construct validity. Journal of Bone and Joint Surgery, 14: 182-192, 1996.
  11. Dauphinee SW, Gauthier L, Gandek B, Magnan L, Pierre U. Readying a US measure of health status, the SF-36, for use in Canada. Clinical and Investigative Medicine, 20: 224- 238, 1997.
  12. Sampalis JS, Pouchot J, Beaudet F, Carette S, Gutkowski A., Harth M., Myhal D, Senecal J, Yeadon C, Williams JI, Esdaile JM. Arthritis impact measurement scales: reliability of a French version and validity in adult Still's disease. Journal of Rheumatology, 17: 1657-1661.
  13. Fullerton JT, Wallace HM, Concha-Garcia S. Development and translation of an English-Spanish dual-language instrument addressing access to prenatal care for the border-dwelling Hispanic women of San Diego County. Journal of nurse-Midwifery, 38: 45-50, 1993.
  14. Hendricson WD. Russell IJ. Prihoda TJ. Jacobson JM. Rogan A. Bishop GD. Castillo R. Development and initial validation of a dual-language English-Spanish format for the arthritis impact measurement scales. Arthritis and Rheumatism, 32: 1153-9, 1989.
  15. Engelberg R, Martin DP, Agel J, Swiontkowski MF. Musculoskeletal Function Assessment: reference values for patient and non-patient samples. Journal of Orthopaedic research, 17: 101-109, 1999.

Downloads

Download data is not yet available.